Literature DB >> 11145233

A strategy for primary high throughput cytotoxicity screening in pharmaceutical toxicology.

P J Bugelski1, U Atif, S Molton, I Toeg, P G Lord, D G Morgan.   

Abstract

PURPOSE: Recent advances in combinatorial chemistry and high throughput screens for pharmacologic activity have created an increasing demand for in vitro high throughput screens for toxicological evaluation in the early phases of drug discovery.
METHODS: To develop a strategy for such a screen, we have conducted a data mining study of the National Cancer Institute's Developmental Therapeutics Program (DTP) cytotoxicity database.
RESULTS: Using hierarchical cluster analysis, we confirmed that the different tissues of origin and individual cell lines showed differential sensitivity to compounds in the DTP Standard Agents database. Surprisingly, however, approaching the data globally, linear regression analysis showed that the differences were relatively minor. Comparison with the literature on acute toxicity in mice showed that the predictive power of growth inhibition was marginally superior to that of cell death.
CONCLUSIONS: This datamining study suggests that in designing a strategy for high throughput cytotoxicity screening: a single cell line, the choice of which may not be critical, can be used as a primary screen; a single end point may be an adequate measure and a cut off value for 50% growth inhibition between 10(-6) and 10(-8) M may be a reasonable starting point for accepting a cytotoxic compound for scale up and further study.

Entities:  

Mesh:

Year:  2000        PMID: 11145233     DOI: 10.1023/a:1026495503939

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  26 in total

1.  Mouse and large-animal toxicology studies of twelve antitumor agents: relevance to starting dose for phase I clinical trials.

Authors:  J S Penta; M Rozencweig; A M Guarino; F M Muggia
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

Review 2.  Hepatotoxicity in drug development: detection, significance and solutions.

Authors:  F Ballet
Journal:  J Hepatol       Date:  1997       Impact factor: 25.083

Review 3.  Application of combinatorial library methods in cancer research and drug discovery.

Authors:  K S Lam
Journal:  Anticancer Drug Des       Date:  1997-04

4.  IRAG working group 4. Cell cytotoxicity assays. Interagency Regulatory Alternatives Group.

Authors:  J W Harbell; S W Koontz; R W Lewis; D Lovell; D Acosta
Journal:  Food Chem Toxicol       Date:  1997-01       Impact factor: 6.023

5.  Diversity of metallothionein content and subcellular localization in the National Cancer Institute tumor panel.

Authors:  E S Woo; A Monks; S C Watkins; A S Wang; J S Lazo
Journal:  Cancer Chemother Pharmacol       Date:  1997       Impact factor: 3.333

6.  An information-intensive approach to the molecular pharmacology of cancer.

Authors:  J N Weinstein; T G Myers; P M O'Connor; S H Friend; A J Fornace; K W Kohn; T Fojo; S E Bates; L V Rubinstein; N L Anderson; J K Buolamwini; W W van Osdol; A P Monks; D A Scudiero; E A Sausville; D W Zaharevitz; B Bunow; V N Viswanadhan; G S Johnson; R E Wittes; K D Paull
Journal:  Science       Date:  1997-01-17       Impact factor: 47.728

7.  [Place of in vitro models in preclinical evaluation of anticancer drugs].

Authors:  J Robert
Journal:  Bull Cancer       Date:  1996-10       Impact factor: 1.276

8.  Quantitative prediction of drug toxicity in humans from toxicology in small and large animals.

Authors:  M A Goldsmith; M Slavik; S K Carter
Journal:  Cancer Res       Date:  1975-05       Impact factor: 12.701

9.  Application of pharmacokinetically guided dose escalation with respect to cell cycle phase specificity.

Authors:  E Fuse; S Kobayashi; M Inaba; H Suzuki; Y Sugiyama
Journal:  J Natl Cancer Inst       Date:  1994-07-06       Impact factor: 13.506

Review 10.  Cultured hepatocytes as investigational models for hepatic toxicity: practical applications in drug discovery and development.

Authors:  R G Ulrich; J A Bacon; C T Cramer; G W Peng; D K Petrella; R P Stryd; E L Sun
Journal:  Toxicol Lett       Date:  1995-12       Impact factor: 4.372

View more
  4 in total

1.  Synthesis, characterization, and NMR studies of 1,2,3-triazolium ionic liquids: a good perspective regarding cytotoxicity.

Authors:  Nicolas Glanzmann; Arturene M L Carmo; Luciana M R Antinarelli; Elaine S Coimbra; Luiz Antônio S Costa; Adilson D da Silva
Journal:  J Mol Model       Date:  2018-06-14       Impact factor: 1.810

2.  Cytotoxic and antimicrobial activity of pseudopterosins and seco-pseudopterosins isolated from the octocoral Pseudopterogorgia elisabethae of San Andrés and Providencia Islands (Southwest Caribbean Sea).

Authors:  Hebelin Correa; Fabio Aristizabal; Carmenza Duque; Russell Kerr
Journal:  Mar Drugs       Date:  2011-03-04       Impact factor: 5.118

3.  Safety evaluation of chinese medicine injections with a cell imaging-based multiparametric assay revealed a critical involvement of mitochondrial function in hepatotoxicity.

Authors:  Meng Wang; Chen-Xiang Liu; Ran-Ran Dong; Shuang He; Ting-Ting Liu; Tie-Chan Zhao; Zhi-Long Wang; Xi-Ya Shen; Bo-Li Zhang; Xiu-Mei Gao; Yan Zhu
Journal:  Evid Based Complement Alternat Med       Date:  2015-02-22       Impact factor: 2.629

4.  Inhibitory Effects of Erythrosine/Curcumin Derivatives/Nano-Titanium Dioxide-Mediated Photodynamic Therapy on Candida albicans.

Authors:  Kasama Kanpittaya; Aroon Teerakapong; Noppawan Phumala Morales; Doosadee Hormdee; Aroonsri Priprem; Wilawan Weera-Archakul; Teerasak Damrongrungruang
Journal:  Molecules       Date:  2021-04-21       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.